Authors

• Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
• Elizabeth K. Seng (ORCID: https://orcid.org/0000-0002-8938-4949)
• Mia T. Minen (ORCID: https://orcid.org/0000-0002-4991-3703)
• Ryan C. Bostic (ORCID: https://orcid.org/0009-0005-2034-2934)
• Benjamin W. Friedman (ORCID: https://orcid.org/0000-0002-2753-5860)
• Scott W. Powers (ORCID: https://orcid.org/0000-0002-5348-9650)
• Kristina M. Fanning (ORCID: https://orcid.org/0000-0001-8072-1489)
• Alexis George (ORCID: https://orcid.org/0000-0002-4252-6858)

Institutions

• The Graduate Center, CUNY (US)
• Cincinnati Children's Hospital Medical Center (US)
• Albert Einstein College of Medicine (US)
• City University of New York (US)
• Yeshiva University (US)
• NYU Langone Health (US)
• Statistical Research (United States) (US)

Publication Details

Journal

JAMA Network Open

Published

2025-10-16

DOI

https://doi.org/10.1001/jamanetworkopen.2025.34221

Citations

1

Primary Topic

Migraine and Headache Studies

Type

article

Field-Weighted Citation Impact

1.47

Funders

• Alzheimer's Association
• Amgen
• Eli Lilly and Company
• Pfizer
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• York University
• H. Lundbeck A/S
• Grifols
• National Institutes of Health
• U.S. Food and Drug Administration
• Allergan
• National Center for Advancing Translational Sciences
• National Center for Complementary and Integrative Health